Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Professor Michael Dustin on his election as a member of the European Molecular Biology Organisation (EMBO).

Professor Dustin was one of 65 outstanding life scientists to be elected to its membership, joining a group of more than 1700 of the best researchers in Europe and around the world.

Professor Michael Dustin joins Professor Fiona Powrie and Sir Marc Feldman as EMBO members from the Kennedy Institute of Rheumatology.

EMBO Director Maria Leptin said:

“Election to the EMBO Membership is recognition of research excellence, and I am pleased to welcome so many great scientists to our organisation.”

She continues: “We received more nominations than ever before during this election cycle, which pays tribute to the strength and diversity of the European life sciences. Drawing on our new members’ expertise and insight will be invaluable in helping EMBO to deliver and strengthen its programmes and activities in the years to come.”

Professor Dustin exclaimed:

“It’s an honour to be elected a member of EMBO only a few years after arriving here in the UK. I look forward to contributing to EMBO’s mission in years to come.”

EMBO Members are actively involved in the execution of the organisation’s initiatives by evaluating applications for EMBO funding and by serving on EMBO Council, Committees and Editorial Boards.

An online directory with all existing and new EMBO Members is available at people.embo.org.

Similar stories

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Drug may boost vaccine responses in older adults

General Research

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards Funding

Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Awards General

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.

Wellcome funding awarded to Oxford team to support research into heart muscle regeneration

Awards Research

An Oxford team from the Centre for Medicines Development, Department of Physiology Anatomy and Genetics and Radcliffe Department of Medicine led by Professor Jagdeep Nanchahal at the Kennedy Institute has been awarded a Wellcome Innovator Award to develop a first in class therapeutic aimed at regenerating heart muscle after heart attack.

NDORMS researchers make Highly Cited Researchers list

Awards

Professor Gary Collins, Professor Cyrus Cooper, Professor Fiona Powrie and the late Professor Doug Altman have been named on the annual Highly Cited Researchers™️ 2020 list from Clarivate.